{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:49:03Z","timestamp":1776235743868,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS062327-01A2"],"award-info":[{"award-number":["R01NS062327-01A2"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1I01BX004269-01"],"award-info":[{"award-number":["1I01BX004269-01"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"South Carolina State Spinal Cord Research Fund","award":["SCIRF-2015P-01, SCIRF-2015P-04, SCIRF-2015-I-01, SCIRF-2016 I-03, and SCIRF #2018 I-01"],"award-info":[{"award-number":["SCIRF-2015P-01, SCIRF-2015P-04, SCIRF-2015-I-01, SCIRF-2016 I-03, and SCIRF #2018 I-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12640-020-00264-3","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T07:02:28Z","timestamp":1596697348000},"page":"640-649","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cell-Permeable Calpain Inhibitor SJA6017 Provides Functional Protection to Spinal Motoneurons Exposed to MPP+"],"prefix":"10.1007","volume":"38","author":[{"given":"Supriti","family":"Samantaray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varduhi H.","family":"Knaryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"M. Del Re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald C.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapan K.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naren L.","family":"Banik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"key":"264_CR1","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jocn.2007.08.011","volume":"15","author":"O Akdemir","year":"2008","unstructured":"Akdemir O, U\u00e7ankale M, Karao\u011flan A, Barut S, Sa\u011fmanligil A, Bilguvar K, Cirako\u011flu B, Sahan E, Colak A (2008) Therapeutic efficacy of SJA6017, a calpain inhibitor, in rat spinal cord injury. J Clin Neurosci 15:1130\u20131136","journal-title":"J Clin Neurosci"},{"key":"264_CR2","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1152\/ajpcell.00207.2006","volume":"291","author":"DD Arrington","year":"2006","unstructured":"Arrington DD, Van Vleet TR, Schnellmann RG (2006) Calpain 10: a mitochondrial calpain and its role in calcium-induced mitochondrial dysfunction. Am J Physiol Cell Physiol 291:1159\u20131171","journal-title":"Am J Physiol Cell Physiol"},{"key":"264_CR3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.survophthal.2007.12.006","volume":"53","author":"M Azuma","year":"2008","unstructured":"Azuma M, Shearer TR (2008) The role of calcium-activated protease calpain in experimental retinal pathology. Surv Ophthalmol 53:150\u2013163","journal-title":"Surv Ophthalmol"},{"key":"264_CR4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbadis.2008.11.007","volume":"1792","author":"R Banerjee","year":"2009","unstructured":"Banerjee R, Starkov AA, Beal MF, Thomas B (2009) Mitochondrial dysfunction in the limelight of Parkinson\u2019s disease pathogenesis. Biochim Biophys Acta 1792:651\u2013663","journal-title":"Biochim Biophys Acta"},{"key":"264_CR5","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/BF00964996","volume":"8","author":"NL Banik","year":"1983","unstructured":"Banik NL, Hogan EL, Jenkins MG, McDonald JK, McAlhaney WW, Sostek MB (1983) Purification of a calcium-activated neutral proteinase from bovine brain. Neurochem Res 8:1389\u20131405","journal-title":"Neurochem Res"},{"key":"264_CR6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2004.11.049","volume":"120","author":"D Bano","year":"2005","unstructured":"Bano D, Young KW, Guerin CJ, Lefeuvre R, Rothwell NJ, Naldini L, Rizzuto R, Carafoli E, Nicotera P (2005) Cleavage of the plasma membrane Na+\/Ca2+ exchanger in excitotoxicity. Cell 120:275\u2013285","journal-title":"Cell"},{"key":"264_CR7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/sj.jcbfm.9600595","volume":"28","author":"MB Bevers","year":"2008","unstructured":"Bevers MB, Neumar RW (2008) Mechanistic role of calpains in postischemic neurodegeneration. J Cereb Blood Flow Metab 28:655\u2013673","journal-title":"J Cereb Blood Flow Metab"},{"key":"264_CR8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1139\/o92-061","volume":"70","author":"RE Beyer","year":"1992","unstructured":"Beyer RE (1992) An analysis of the role of coenzyme Q in free radical generation and as an antioxidant. Biochem Cell Biol 70:390\u2013403","journal-title":"Biochem Cell Biol"},{"key":"264_CR9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/B:MCBI.0000028752.89886.43","volume":"261","author":"S Biswas","year":"2004","unstructured":"Biswas S, Harris F, Singh J, Phoenix DA (2004) The in vitro retardation of porcine cataractogenesis by the calpain inhibitor, SJA6017. Mol Cell Biochem 261:169\u2013173","journal-title":"Mol Cell Biochem"},{"key":"264_CR10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jnr.21882","volume":"87","author":"JT Butler","year":"2009","unstructured":"Butler JT, Samantaray S, Beeson CC, Ray SK, Banik NL (2009) Involvement of calpain in the process of Jurkat T cell chemotaxis. J Neurosci Res 87:626\u2013635","journal-title":"J Neurosci Res"},{"key":"264_CR11","doi-asserted-by":"crossref","first-page":"e0215277","DOI":"10.1371\/journal.pone.0215277","volume":"14","author":"N Callizot","year":"2019","unstructured":"Callizot N, Combes M, Henrigues A, Poindron P (2019) Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins. PLoS One 14:e0215277","journal-title":"PLoS One"},{"key":"264_CR12","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/brain\/aws133","volume":"135","author":"Y Chu","year":"2012","unstructured":"Chu Y, Morfini GA, Langhamer LB, He Y, Brady ST, Kordower JH (2012) Alterations in axonal transport motor proteins in sporadic and experimental Parkinson\u2019s disease. Brain 135:2058\u20132073","journal-title":"Brain"},{"key":"264_CR13","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1471-4159.1992.tb09789.x","volume":"58","author":"MWJ Cleeter","year":"1992","unstructured":"Cleeter MWJ, Cooper JM, Schapira AHV (1992) Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J Neurochem 58:786\u2013789","journal-title":"J Neurochem"},{"key":"264_CR14","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1523\/JNEUROSCI.12-09-03392.1992","volume":"12","author":"GD Crawford","year":"1992","unstructured":"Crawford GD, Le WD, Smith RG, Xie WJ, Stefani E, Appel SH (1992) A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J Neurosci 12:3392\u20133398","journal-title":"J Neurosci"},{"key":"264_CR15","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1046\/j.1471-4159.1994.63041558.x","volume":"63","author":"KS DeJongh","year":"1994","unstructured":"DeJongh KS, Colvin AA, Wang KK, Catterall WA (1994) Differential proteolysis of the full-length form of the L-type calcium channel alpha 1 subunit by calpain. J Neurochem 63:1558\u20131564","journal-title":"J Neurochem"},{"key":"264_CR16","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci 106:13010\u201313015","journal-title":"Proc Natl Acad Sci"},{"key":"264_CR17","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2353\/ajpath.2007.061232","volume":"170","author":"BM Dufty","year":"2007","unstructured":"Dufty BM, Warner LR, Hou ST, Jiang SX, Gomez-Isla T, Leenhouts KM, Oxford JT, Feany MB, Masliah E, Rohn TT (2007) Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation. Am J Pathol 170:1725\u20131738","journal-title":"Am J Pathol"},{"key":"264_CR18","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1152\/physrev.00029.2002","volume":"83","author":"DE Goll","year":"2003","unstructured":"Goll DE, Thompson VF, Li H, Wei W, Cong J (2003) The calpain system. Physiol Rev 83:731\u2013801","journal-title":"Physiol Rev"},{"key":"264_CR19","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","volume":"260","author":"G Grynkiewicz","year":"1985","unstructured":"Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440\u20133450","journal-title":"J Biol Chem"},{"key":"264_CR20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0891-0618(98)00065-9","volume":"16","author":"PR Hof","year":"1999","unstructured":"Hof PR, Glezer IL, Conde F, Flagg RA, Rubin MB, Nimchinsky EA, Vogt Weisenhorn DM (1999) Cellular distribution of the calcium-binding proteins parvalbumin, calbindin, and calretinin in the neocortex of mammals: phylogenetic and developmental patterns. J Cem Neuroanat 16:77\u2013116","journal-title":"J Cem Neuroanat"},{"key":"264_CR21","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1021\/jm0201924","volume":"46","author":"J Inoue","year":"2003","unstructured":"Inoue J, Nakamura M, Cui YS, Sakai Y, Sakai O, Hill JR, Wang KK, Yuen PW (2003) Structure-activity relationship study and drug profile of N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal (SJA6017) as a potent calpain inhibitor. J Med Chem 46:868\u2013871","journal-title":"J Med Chem"},{"key":"264_CR22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/01.RES.0000181170.87738.f3","volume":"97","author":"J Inserte","year":"2005","unstructured":"Inserte J, Garcia-Dorado D, Hernando V, Soler-Soler J (2005) Calpain-mediated impairment of Na+\/K+-ATPase activity during early reperfusion contributes to cell death after myocardial ischemia. Circ Res 97:465\u2013473","journal-title":"Circ Res"},{"key":"264_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2009.12.020","volume":"495","author":"P Kar","year":"2010","unstructured":"Kar P, Samanta K, Shaikh S, Chowdhury A, Chakraborti T, Chakraborti S (2010) Mitochondrial calpain system: an overview. Arch Biochem Biophys 495:1\u20137","journal-title":"Arch Biochem Biophys"},{"key":"264_CR24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0003-9861(88)90509-7","volume":"260","author":"GE Kass","year":"1988","unstructured":"Kass GE, Wright JM, Nicotera P, Orrenius S (1988) The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium. Arch Biochem Biophys 260:789\u2013797","journal-title":"Arch Biochem Biophys"},{"key":"264_CR25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1471-4159.2012.07859.x","volume":"123","author":"CM Kopil","year":"2012","unstructured":"Kopil CM, Siebert AP, Foskett JK, Neumar RW (2012) Calpain-cleaved type 1 inositol 1,4,5-trisphosphate receptor impairs ER Ca(2+) buffering and causes neurodegeneration in primary cortical neurons. J Neurochem 123:147\u2013158","journal-title":"J Neurochem"},{"key":"264_CR26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/molecules20010135","volume":"20","author":"P Kumar","year":"2014","unstructured":"Kumar P, Choonara YE, Pillay V (2014) In silico affinity profiling of neuroactive polyphenols for post-traumatic calpain inactivation: a molecular docking and atomistic simulation sensitivity analysis. Molecules 20:135\u2013168","journal-title":"Molecules"},{"key":"264_CR27","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1089\/089771501317095269","volume":"18","author":"NC Kupina","year":"2001","unstructured":"Kupina NC, Nath R, Bernath EE, Inoue J, Mitsuyoshi A, Yuen PW, Wang KK, Hall ED (2001) The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury. J Neurotrauma 18:1229\u20131240","journal-title":"J Neurotrauma"},{"key":"264_CR28","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/brain\/awp333","volume":"133","author":"S Levesque","year":"2010","unstructured":"Levesque S, Wilson B, Gregoria V, Thorpe LB, Dallas S, Polikov VS, Hong JS, Block ML (2010) Reactive microgliosis: extracellular micro-calpain and microglia-mediated dopaminergic neurotoxicity. Brain 133:808\u2013821","journal-title":"Brain"},{"key":"264_CR29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0006-8993(00)02926-7","volume":"885","author":"BS Mandavilli","year":"2000","unstructured":"Mandavilli BS, Ali SF, Van Houten B (2000) DNA damage in brain mitochondria caused by aging and MPTP treatment. Brain Res 885:45\u201352","journal-title":"Brain Res"},{"key":"264_CR30","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1111\/j.1471-4159.1987.tb05737.x","volume":"48","author":"Y Mizuno","year":"1987","unstructured":"Mizuno Y, Sone N, Saitoh T (1987) Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain. J Neurochem 48:1787\u20131793","journal-title":"J Neurochem"},{"key":"264_CR31","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/0006-291X(89)91141-8","volume":"163","author":"Y Mizuno","year":"1989","unstructured":"Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson\u2019s disease. Biochem Biophys Res Commun 163:1450\u20131455","journal-title":"Biochem Biophys Res Commun"},{"key":"264_CR32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0143-4160(03)00144-1","volume":"34","author":"DG Nicholls","year":"2003","unstructured":"Nicholls DG, Vesce S, Kirk L, Chalmers S (2003) Interactions between mitochondrial bioenergetics and cytoplasmic calcium in cultured cerebellar granule cells. Cell Calcium 34:407\u2013424","journal-title":"Cell Calcium"},{"key":"264_CR33","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0024-3205(87)90299-2","volume":"40","author":"WJ Nicklas","year":"1987","unstructured":"Nicklas WJ, Youngster SK, Kindt MV, Heikkila RE (1987) MPTP, MPP+ and mitochondrial function. Life Sci 40:721\u2013729","journal-title":"Life Sci"},{"key":"264_CR34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jb\/mvm143","volume":"142","author":"T Ozaki","year":"2007","unstructured":"Ozaki T, Tomita H, Tamai M, Ishiguro S (2007) Characteristics of mitochondrial calpains. J Biochem 142:365\u2013376","journal-title":"J Biochem"},{"key":"264_CR35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.brainres.2007.10.061","volume":"1189","author":"WD Parker Jr","year":"2008","unstructured":"Parker WD Jr, Parks JK, Swerdlow RH (2008) Complex I deficiency in Parkinson\u2019s disease frontal cortex. Brain Res 1189:215\u2013218","journal-title":"Brain Res"},{"key":"264_CR36","first-page":"135","volume":"16","author":"S Przedborski","year":"2000","unstructured":"Przedborski S, Jackson-Lewis V, Djaldetti R et al (2000) The parkinsonian toxin MPTP: action and mechanism. Restor Neurol Neurosci 16:135\u2013142","journal-title":"Restor Neurol Neurosci"},{"key":"264_CR37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuroscience.2011.06.007","volume":"192","author":"S Samantaray","year":"2011","unstructured":"Samantaray S, Knaryan VH, Le Gal C, Ray SK, Banik NL (2011) Calpain inhibition protected spinal cord motoneurons against 1-methyl-4-phenylpyridinium ion and rotenone. Neuroscience 192:263\u2013274","journal-title":"Neuroscience"},{"key":"264_CR38","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/s12035-015-9255-6","volume":"52","author":"S Samantaray","year":"2015","unstructured":"Samantaray S, Knaryan VH, Shields DC, Cox AA, Haque A, Banik NL (2015) Inhibition of Calpain activation protects MPTP-induced nigral and spinal cord neurodegeneration, reduces inflammation, and improves gait dynamics in mice. Mol Neurobiol 52:1054\u20131066","journal-title":"Mol Neurobiol"},{"key":"264_CR39","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","volume":"54","author":"AHV Schapira","year":"1990","unstructured":"Schapira AHV, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD (1990) Mitochondrial complex I deficiency in Parkinson\u2019s disease. J Neurochem 54:823\u2013827","journal-title":"J Neurochem"},{"key":"264_CR40","first-page":"192","volume":"8","author":"TB Sherer","year":"2002","unstructured":"Sherer TB, Betarbet R, Greenamyre JT (2002) Environment, mitochondria, and Parkinson\u2019s disease. Neuroscientist 8:192\u2013197","journal-title":"Neuroscientist"},{"key":"264_CR41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/cvr\/cvs163","volume":"96","author":"MA Smith","year":"2012","unstructured":"Smith MA, Schnellmann RG (2012) Calpains, mitochondria, and apoptosis. Cardiovasc Res 96:32\u201337","journal-title":"Cardiovasc Res"},{"key":"264_CR42","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1523\/JNEUROSCI.2875-05.2006","volume":"26","author":"PD Smith","year":"2006","unstructured":"Smith PD, Mount MP, Shree R, Callaghan S, Slack RS, Anisman H, Vincent I, Wang X, Mao Z, Park DS (2006) Calpain-regulated p35\/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2. J Neurosci 26:440\u2013447","journal-title":"J Neurosci"},{"key":"264_CR43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/bj1800129","volume":"180","author":"K Takeshige","year":"1979","unstructured":"Takeshige K, Minakami S (1979) NADH- and NADPH-dependent formation of superoxide anions by bovine heart submitochondrial particles and NADH-ubiquinone reductase preparation. Biochem J 180:129\u2013135","journal-title":"Biochem J"},{"key":"264_CR44","first-page":"133","volume":"91","author":"CM Tanner","year":"2003","unstructured":"Tanner CM (2003) Is the cause of Parkinson\u2019s disease environmental or hereditary? Evidence from twin studies. Adv Neurol 91:133\u2013142","journal-title":"Adv Neurol"},{"key":"264_CR45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12035-008-8036-x","volume":"38","author":"PS Vosler","year":"2008","unstructured":"Vosler PS, Brennan CS, Chen J (2008) Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol Neurobiol 38:78\u2013100","journal-title":"Mol Neurobiol"},{"key":"264_CR46","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1002\/ana.10487","volume":"53","author":"TT Warner","year":"2003","unstructured":"Warner TT, Schapira AH (2003) Genetic and environmental factors in the cause of Parkinson\u2019s disease. Ann Neurol 53:S16\u2013S23","journal-title":"Ann Neurol"},{"key":"264_CR47","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1017\/S1461145706007061","volume":"10","author":"MW Warren","year":"2007","unstructured":"Warren MW, Zheng W, Kobeissy FH, Cheng Liu M, Hayes RL, Gold MS, Larner SF, Wang KK (2007) Calpain- and caspase-mediated alphaII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure. Int J Neuropsychopharmacol 10:479\u2013489","journal-title":"Int J Neuropsychopharmacol"},{"key":"264_CR48","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.3892\/mmr.2017.6341","volume":"15","author":"H Zhao","year":"2017","unstructured":"Zhao H, Xu M, Chu G (2017) Association between myocardial cell apoptosis and calpain-1\/caspase-3 expression in rats with hypoxic-ischemic brain damage. Mol Med Rep 15:2727\u20132731","journal-title":"Mol Med Rep"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-020-00264-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12640-020-00264-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-020-00264-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T23:17:51Z","timestamp":1628205471000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12640-020-00264-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["264"],"URL":"https:\/\/doi.org\/10.1007\/s12640-020-00264-3","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]},"assertion":[{"value":"23 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"No human or animal subjects were included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}